Literature DB >> 26201949

Needle detachment in a slim and physically active child with insulin pump treatment.

Christine Moser1, Kathrin Maurer2, Elisabeth Binder1, Dagmar Meraner1, Elisabeth Steichen1, Daniela Abt1, Karin Freund-Unsinn2, Sabine E Hofer1.   

Abstract

Insulin pump therapy (CSII) is well established in pediatric patients with type 1 diabetes. In childhood diabetes, insulin pump treatment shows considerable advantages such as fewer injections, increased flexibility, fewer hypoglycemic events and lower HbA1c levels. Side effects such as catheter obstruction, technical pump failure, and dermatological complications have been observed, but are rarely reported. The reported patient is a physically very active and slim 10-year-old boy with reduced subcutaneous fatty tissue. After strong muscular activity an accidental rupture of the infusion set and needle detachment occurred in October 2013. X-ray and ultrasound imaging localized the needle in the musculus rectus femoris dexter. The needle was kept in situ and oral antibiotic treatment to prevent inflammatory reaction was prescribed. Repeated ultrasound measurements documented that the needles position had remained unchanged. Steel needle catheters (Sure-T infusion set, 6 mm) positioned in a thin layer of subcutaneous fat tissue of the thigh, combined with intense sports activity can result in a needle rupture and penetration into the muscle. Careful monitoring provides an alternative to surgery and lowers the risk of muscular necrosis. Because of differences in the distribution of subcutaneous fat tissue, an individualized catheter selection is necessary in pump treatment for children and adolescents, requiring a variety of different catheter sets.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  catheter complication; complication of insulin pump treatment; insulin pump treatment; needle detachment

Mesh:

Year:  2015        PMID: 26201949     DOI: 10.1111/pedi.12297

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  4 in total

Review 1.  Replacing Pumps with Light Controlled Insulin Delivery.

Authors:  Simon H Friedman
Journal:  Curr Diab Rep       Date:  2019-11-06       Impact factor: 4.810

2.  Visible-Light-Activated High-Density Materials for Controlled in Vivo Insulin Release.

Authors:  Bhagyesh R Sarode; Karen Kover; Simon H Friedman
Journal:  Mol Pharm       Date:  2019-10-24       Impact factor: 4.939

3.  Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review.

Authors:  Carolina Spinelli Alvarenga; Rebecca Ortiz La Banca; Rhyquelle Rhibna Neris; Valéria de Cássia Sparapani; Miguel Fuentealba-Torres; Denisse Cartagena-Ramos; Camila Lima Leal; Marcos Venicio Esper; Lucila Castanheira Nascimento
Journal:  BMC Endocr Disord       Date:  2022-02-19       Impact factor: 2.763

4.  Light Control of Insulin Release and Blood Glucose Using an Injectable Photoactivated Depot.

Authors:  Bhagyesh R Sarode; Karen Kover; Pei Y Tong; Chaoying Zhang; Simon H Friedman
Journal:  Mol Pharm       Date:  2016-10-15       Impact factor: 4.939

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.